$664MEquity raised, all time3 equity rounds sourced so far
$3BLatest valuationpost-money, as reported
Rounds over time log-scaled amounts
Funding history 3 rounds · 5 sources · newest first
Earlier rounds not yet sourced. Pathos AI was founded in 2021 and raised before 29 Oct 2024; only the rounds below are sourced so far, so its all-time equity total understates its history.
Series E
Amount$237M
Post-money$3B
✓ Confirmed
Lead
Bristol Myers Squibb
Note
Led by Bristol Myers Squibb with unnamed existing investors; announced alongside BMS and Tempus AI collaborations. Approximately $3B post-money.
Oversubscribed; $600M post-money. Company stated total funding of $102M including this round; earlier rounds not sourced here. Release datelined Chicago.
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Pathos AI and its logo are trademarks of their owners, used here for identification only.